Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Where do we stand with BCG vaccination programme in Japan?].

T Mori1

  • 1Tuberculosis Research Institute, Japan Anti-Tuberculosis Association, Tokyo, Japan.

Kekkaku : [Tuberculosis]
|June 12, 2001
PubMed
Summary

Japan's BCG vaccination program shows overall effectiveness in reducing tuberculosis rates in young children, despite ongoing debates about revaccination efficacy and program discontinuation. Cost-effectiveness analysis suggests continued benefit.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Schedule-dependent inhibition of thymidylate synthase by 5-fluorouracil in gastric cancer.

Cancer·1992
Same author

Heterophile antigens in serous cystadenocarcinoma of the human ovary.

Asia-Oceania journal of obstetrics and gynaecology·1992
Same author

Evaluation of an improved dot-immunobinding assay for carcinoembryonic antigen determination in nipple discharge in early breast cancer: results of a multicenter study.

Japanese journal of clinical oncology·1992
Same author

The effect of DHAS on steroidogenesis of the human corpus luteum.

Endocrinologia japonica·1992
Same author

The characteristics of interval breast cancer in mass screening.

The Tokushima journal of experimental medicine·1992
Same author

[The relationship between evaluation of school stressors and stress responses in junior high school students].

Shinrigaku kenkyu : The Japanese journal of psychology·1992

Area of Science:

  • Immunology and Public Health
  • Epidemiology
  • Vaccinology

Context:

  • The current Bacillus Calmette-Guérin (BCG) vaccination program in Japan is critically evaluated.
  • Recent epidemiological data and scientific knowledge are considered to inform future tuberculosis control strategies.
  • The program's efficacy, effectiveness, and cost-benefit are analyzed in the context of global recommendations and national health policies.

Purpose:

  • To critically assess the current BCG vaccination program in Japan.
  • To analyze the epidemiological aspects, efficacy, and effectiveness of BCG vaccination.
  • To provide a perspective for Japan's future tuberculosis control program, including decisions on vaccination discontinuation.

Summary:

  • BCG vaccination in Japan demonstrates overall effectiveness, evidenced by lower tuberculosis notification rates in young children compared to the USA.

Related Experiment Videos

  • Two proposed mechanisms for BCG efficacy (lasting immunity vs. aborting infection) are discussed, with epidemiological models favoring the former.
  • Revaccination effectiveness is limited, and its benefits must be weighed against potential demerits, especially in the current Japanese epidemiological context.

    • Impact:

    • The analysis suggests that the current Japanese BCG vaccination program, despite its cost, remains cost-effective compared to historical discontinuation benchmarks.
    • The study highlights the need for careful consideration of epidemiological trends and cost-benefit analyses when making decisions about public health vaccination programs.
    • Findings provide crucial insights for policymakers regarding the ongoing role and potential adjustments of the BCG vaccination program in Japan's tuberculosis control efforts.